Quick Takeaways
- T. Rowe Price Investment Management, Inc. filed SCHEDULE 13G for JASPER THERAPEUTICS INC COMMON STOCK (JSPR).
- Disclosed ownership: 7.1%.
- Date of event: 30 Sep 2025.
T. Rowe Price Investment Management, Inc. - 30 Sep 2025 SCHEDULE 13G Report for JASPER THERAPEUTICS INC COMMON STOCK (JSPR)
- Filing Manager
- T. Rowe Price Investment Management, Inc.
- Reporting Manager
- T. Rowe Price Investment Management, Inc.
- Security
- JASPER THERAPEUTICS INC COMMON STOCK
- Symbol
- JSPR
- Shares outstanding
- 28,980,451 shares
- Disclosed Ownership
- 2,057,612 shares
- Ownership
- 7.1%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Nov 2025, 12:18:24 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"T. Rowe Price Investment Management, Inc. disclosed 7.1% ownership in JASPER THERAPEUTICS INC COMMON STOCK (JSPR) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 12:18.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 7.1% | 2,057,612 | 1,028,806 | 0 | Ellen York | Vice President |